Section Arrow
Quote
ATTO.NASDAQ
- Attovia Therapeutics Inc
Quotes are at least 15-min delayed:2026/11/06 18:05 EST
After Hours
Last
 15.27
0 (0.00%)
Bid
15.19
Ask
15.27
High 15.27 
Low 15.27 
Volume 1.12K 
Regular Hours (Closed)
Last
 15.27
+0.27 (+1.80%)
Day High 
15.5 
Prev. Close
15 
1-M High
18.375 
Volume 
218.75K 
Bid
15.19
Ask
15.27
Day Low
14.93 
Open
14.93 
1-M Low
12.94 
Market Cap 
684.77M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 14.99 
20-SMA 14.77 
50-SMA 18.28 
52-W High 28 
52-W Low 12.94 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.64/-2.38
Enterprise Value
688.11M
Balance Sheet
Book Value Per Share
-3.19
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
1.35M
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
KPTIKaryopharm Therapeutics Inc.0.0549-0.0052-8.65%-- 
After Hours 0.045898 -0.009002 -16.40%
INOInovio Pharmaceuticals1.215-0.235-16.21%-- 
After Hours 1.24 +0.025 +2.06%
LABTLakewood-Amedex Biotherapeutics Inc0.3863-0.1543-28.54%-- 
After Hours 0.3978 +0.0115 +2.98%
CDTCdt Equity Inc1.31+0.464+54.85%0PE
After Hours 1.17 -0.14 -10.69%
MRNAModerna254.19+12.73+5.27%-- 
After Hours 256.01 +1.82 +0.72%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.